Intellia Therapeutics Stock Price on February 6, 2025
| NTLA Stock | USD 9.38 0.18 1.88% |
If you're considering investing in Intellia Stock, it is important to understand the factors that can impact its price. As of today, the current price of Intellia Therapeutics stands at 9.38, as last reported on the 30th of June, with the highest price reaching 9.68 and the lowest price hitting 9.33 during the day. Intellia Therapeutics appears to be somewhat reliable, given 3 months investment horizon. Intellia Therapeutics holds Efficiency (Sharpe) Ratio of 0.13, which attests that the entity had a 0.13 % return per unit of risk over the last 3 months. By evaluating Intellia Therapeutics' technical indicators, you can evaluate if the expected return of 0.76% is justified by implied risk. Please utilize Intellia Therapeutics' Risk Adjusted Performance of 0.216, downside deviation of 6.37, and Market Risk Adjusted Performance of (240.70) to validate if our risk estimates are consistent with your expectations. Intellia Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Intellia Therapeutics Valuation on February 6, 2025
It is possible to determine the worth of Intellia Therapeutics on a given historical date. On February 6, 2025 Intellia was worth 10.63 at the beginning of the trading date compared to the closed value of 10.13. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Intellia Therapeutics stock. Still, in general, we apply an absolute valuation method to find Intellia Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Intellia Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Intellia Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 9.76 | 10.63 | 9.72 | 10.51 | 2,626,289 | |
02/06/2025 | 10.63 | 10.73 | 10.07 | 10.13 | 2,581,322 |
| 10.07 | 10.43 | 9.72 | 9.79 | 2,061,362 |
| Backtest Intellia Therapeutics | | | Intellia Therapeutics History | | | Intellia Therapeutics Valuation | Previous | Next |
Intellia Therapeutics Trading Date Momentum on February 6, 2025
| On February 07 2025 Intellia Therapeutics was traded for 9.79 at the closing time. The top price for the day was 10.43 and the lowest listed price was 9.72 . The trading volume for the day was 2.1 M. The trading history from February 7, 2025 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 3.36% . The trading delta at closing time against the current closing price is 8.00% . |
Intellia Therapeutics Fundamentals Correlations and Trends
By evaluating Intellia Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Intellia Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Intellia financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Intellia Therapeutics Stock history
Intellia Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Intellia is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Intellia Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Intellia Therapeutics stock prices may prove useful in developing a viable investing in Intellia Therapeutics
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. Intellia Thera operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 485 people.
Intellia Therapeutics Stock Technical Analysis
Intellia Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Intellia Therapeutics Period Price Range
Low | June 30, 2025
| High |
0.00 | 0.00 |
Intellia Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Intellia Therapeutics June 30, 2025 Market Strength
Market strength indicators help investors to evaluate how Intellia Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Intellia Therapeutics shares will generate the highest return on investment. By undertsting and applying Intellia Therapeutics stock market strength indicators, traders can identify Intellia Therapeutics entry and exit signals to maximize returns
Intellia Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Intellia Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Intellia Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Intellia to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.216 | |||
| Jensen Alpha | 0.7463 | |||
| Total Risk Alpha | 0.5781 | |||
| Sortino Ratio | 0.1099 | |||
| Treynor Ratio | (240.71) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Intellia Stock analysis
When running Intellia Therapeutics' price analysis, check to measure Intellia Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intellia Therapeutics is operating at the current time. Most of Intellia Therapeutics' value examination focuses on studying past and present price action to predict the probability of Intellia Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intellia Therapeutics' price. Additionally, you may evaluate how the addition of Intellia Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |